In prostate cancer, activated ACK1 promotes tumor growth via androgen receptor (AR) tyrosine phosphorylation, facilitating androgen-independent transactivation of AR (Mahajan et al., 2007) and degradation of tumor suppressor WW domain containing oxidoreductase (Wwox) (Mahajan et al., 2005). This evidence concerns the gene AR and prostate cancer.